NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Jul 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AZEDRA is an intravenous radiopharmaceutical solution containing iobenguane I-131, a targeted radionuclide therapy used to treat neuroendocrine tumors, particularly pheochromocytoma and paraganglioma. It works by selectively targeting and delivering radiation to cells that express the norepinephrine transporter, destroying tumor tissue while minimizing systemic exposure.
Peak
Product is in peak commercial phase with moderate competitive pressure (30); brand teams should expect stable market presence with ongoing optimization of field strategy and market access initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
AZEDRA is a specialized, niche product with zero linked job postings in current market intelligence, indicating a small commercial footprint and limited active hiring. Career opportunities are likely concentrated in specialized medical affairs, market access, and targeted field roles rather than broad brand commercialization teams.
Company
Worked on AZEDRA at Progenicyte Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.